Standout Papers

Alzheimer's disease 2003 2026 2010 2018 1.7k
  1. Alzheimer's disease (2011)
    Clive Ballard, Serge Gauthier et al. The Lancet
  2. Vascular cognitive impairment (2003)
    John T. O’Brien, Timo Erkinjuntti et al. The Lancet Neurology
  3. Putting brain training to the test (2010)
    Adrian M. Owen, Adam Hampshire et al. Nature
  4. Parkinson disease-associated cognitive impairment (2021)
    Dag Aarsland, Lucia Batzu et al. Nature Reviews Disease Primers
  5. Cognitive decline in Parkinson disease (2017)
    Dag Aarsland, Byron Creese et al. Nature Reviews Neurology
  6. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial (2013)
    Jeffrey L. Cummings, Stuart Isaacson et al. The Lancet
  7. Vascular Cognitive Impairment (2014)
    John T. O’Brien, Timo Erkinjuntti et al. International Journal of Stroke
  8. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options (2019)
    Jeffrey L. Cummings, Gary Tong et al. Journal of Alzheimer s Disease
  9. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment (2012)
    Per Svenningsson, Eric Westman et al. The Lancet Neurology
  10. Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers (2022)
    Caroline Holm Nørgaard, Sarah Friedrich et al. Alzheimer s & Dementia Translational Research & Clinical Interventions
  11. Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities (2022)
    Zahinoor Ismail, Byron Creese et al. Nature Reviews Neurology

Immediate Impact

6 by Nobel laureates 6 from Science/Nature 114 standout
Sub-graph 1 of 20

Citing Papers

Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
18 intermediate papers

Works of Clive Ballard being referenced

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
2022 Standout
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
2021
and 20 more

Author Peers

Author Last Decade Papers Cites
Clive Ballard 15559 9813 9065 662 39.6k
Carol Brayne 19317 13130 7977 723 53.7k
Serge Gauthier 15085 11678 4541 560 34.5k
John T. O’Brien 18002 12574 11750 777 44.4k
Dag Aarsland 13490 9337 24797 641 43.1k
Kristine Yaffe 19384 14878 4079 836 62.1k
Richard Mayeux 19443 20883 7316 514 51.2k
Michaël Maes 13686 7073 3057 991 60.6k
Perminder S. Sachdev 15528 6251 3716 969 41.0k
Yaakov Stern 29837 17708 8388 783 65.2k
Hilkka Soininen 15704 16451 3849 672 39.3k

All Works

Loading papers...

Rankless by CCL
2026